For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251120:nRST2671Ia&default-theme=true
RNS Number : 2671I Ampeak Energy Limited 20 November 2025
20 November 2025
AMPEAK ENERGY LIMITED
("Ampeak Energy" or the "Company")
CCR funding completed
Ampeak Energy is pleased to advise that it has received the final tranche of
£3.5m of the £8.5m loan from Cardiff Capital Region ("CCR"), first announced
on 16th April 2025.
The final payment was made following the receipt of planning permission, as
announced on 1 October 2025, and the expiry of the Judicial Review period for
the AW2 battery storage project.
Ampeak Energy will utilise these funds to further accelerate the delivery of
its exciting pipeline of battery storage projects.
For further information, please contact:
Ampeak Energy +44 (0)7739832446
Sean Parsons
Strand Hanson Limited (Nominated and Financial Adviser) +44 (0)20 7409 3494
Richard Johnson
Rory Murphy
David Asquith
Zeus Capital Limited (Broker) +44 (0)20 3829 5000
Louisa Waddell
Simon Johnson
Notes to Editors
Ampeak Energy is a global developer, owner and operator of sustainable energy
projects. Ampeak Energy owns the world's flagship tidal stream project,
MeyGen, and the Uskmouth Power Station site, which is being repurposed into a
sustainable energy park that will become one of the UK's largest battery
energy storage sites. www.ampeak.energy (http://www.ampeak.energy)
Ampeak Energy's strategy: "Building a Sustainable Future to 2035", can be
viewed here (https://ampeak.energy/strategy/)
Proud to be part of London's universe of Green Economy Equities
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCEAAFNFFESFAA
Copyright 2019 Regulatory News Service, all rights reserved